Prime Therapeutics Care Specialists program provides clinical guidance, medication education and ongoing support related to specialty therapies

One of the Prime Together Foundation’s 2023 grants went to TC Food Justice, which works to reduce food waste and hunger in the Twin Cities by linking those willing to help and those in need.

New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey

Mahajan brings more than 20 years of global finance and leadership experience across healthcare, pharmacy and financial services organizations

In its annual fall report dedicated to oncology, Prime Therapeutics highlights strategies to improve outcomes, reduce costs and support patients — starting with a bold approach to managing cancer care

New continuing education course showcases her expertise in biomarker testing and targeted therapy for EGFR-mutated NSCLC

Report features new highlights and rankings of the top 50 drug classes by percent of net spend.

Certification recognizes quality service and continuous improvement

Grant helps provide a home away from home for families facing cancer

Payne to integrate communications, government affairs and policy efforts at leading purpose-driven, transparent PBM

How Prime Therapeutics/Magellan Rx Management reimagines pharmacy to do what's right.

The event emphasizes additional measures for obesity therapy.

Prime is committed to simplifying the cancer care journey through leading oncology solutions designed to support people with cancer

Prime Therapeutics helps simplify the cancer care journey and manage drug costs through leading oncology solutions

Prime Therapeutics experts share more about the latest in precision oncology, including barriers to treatment and the current regulatory landscape

Report encourages providers to consider health contexts and lifestyle modifications as well as personal preferences and current guidelines when prescribing GLP-1s for weight loss

At Pharmacy Benefit Management Institute (PBMI) annual conference, Prime received two awards: one for cost savings, another for leadership.

With open enrollment beginning Oct. 15, Prime highlights Medicare offerings that are helping drive greater value and affordability for plan sponsors and patients

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies